Skip to main content

13.05.2024 | Research

Characterizing “collateral damage” in men and women with metastatic breast cancer (mBC) from diverse racial and ethnic backgrounds in New York City

verfasst von: Shoshana M. Rosenberg, Caroline Zeng, Anjile An, Shakirah N. Ssebyala, Taylor Stein, Gina Lombardo, Desiree Walker, Anne Marie Mercurio, Lauren Elreda, Evelyn Taiwo, Dawn L. Hershman, Laura C. Pinheiro

Erschienen in: Breast Cancer Research and Treatment

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Patients from diverse racial, ethnic, and socio-economic backgrounds may be particularly vulnerable to experiencing undue social and financial burdens (“collateral damage”) from a metastatic breast cancer (mBC) diagnosis; however, these challenges have not been well explored in diverse populations.

Methods

From May 2022 to May 2023, English- or Spanish-speaking adults with mBC treated at four New York-Presbyterian (NYP) sites were invited to complete a survey that assessed collateral damage, social determinants of health, physical and psychosocial well-being, and patient-provider communication. Fisher’s exact and the Kruskal–Wallis rank-sum tests assessed differences by race and ethnicity.

Results

Of 87 respondents, 14% identified as Hispanic, 28% non-Hispanic Black (NHB), 41% non-Hispanic White (NHW), 7% Asian American Pacific Islander (AAPI), and 10% other/multiracial. While 100% of Hispanic, NHW, and AAPI participants reported stable housing, 29% of NHB participants were worried about losing housing (p = 0.002). Forty-two percent of Hispanic and 46% of NHB participants (vs. 8%, NHW and 0%, AAPI, p = 0.005) were food insecure; 18% of Hispanic and 17% of NHB adults indicated lack of reliable transportation in the last year (vs. 0%, NHW/AAPI, p = 0.033). Participants were generally satisfied with the quality of communication that they had with their healthcare providers and overall physical and mental well-being were modestly poorer relative to healthy population norms.

Conclusions

In our study, NHB and Hispanic mBC patients reported higher levels of financial concern and were more likely to experience food and transportation insecurity compared to NHW patients. Systematically connecting patients with resources to address unmet needs should be prioritized to identify feasible approaches to support economically vulnerable patients following an mBC diagnosis.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
5.
Zurück zum Zitat Williams RB, Barefoot JC, Califf RM, Haney TL, Saunders WB, Pryor DB, Hlatky MA, Siegler IC, Mark DB (1992) Prognostic importance of social and economic resources among medically treated patients with angiographically documented coronary artery disease. JAMA 267(4):520–524CrossRefPubMed Williams RB, Barefoot JC, Califf RM, Haney TL, Saunders WB, Pryor DB, Hlatky MA, Siegler IC, Mark DB (1992) Prognostic importance of social and economic resources among medically treated patients with angiographically documented coronary artery disease. JAMA 267(4):520–524CrossRefPubMed
14.
Metadaten
Titel
Characterizing “collateral damage” in men and women with metastatic breast cancer (mBC) from diverse racial and ethnic backgrounds in New York City
verfasst von
Shoshana M. Rosenberg
Caroline Zeng
Anjile An
Shakirah N. Ssebyala
Taylor Stein
Gina Lombardo
Desiree Walker
Anne Marie Mercurio
Lauren Elreda
Evelyn Taiwo
Dawn L. Hershman
Laura C. Pinheiro
Publikationsdatum
13.05.2024
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-024-07347-1

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.